We are proud to announce the official launch of our first overseas division − automed USA.
As a fully owned subsidiary, automed USA will be responsible for the supply and support of the automed platform into the U.S. livestock markets. automed USA will also oversee all U.S. based partnerships and sub-distribution agreements.
automed is a next-generation livestock medication platform. The system provides automatic, accurate dosing and data capture to help producers create a better product at a lower cost.
automed USA – addressing an urgent need
The founder of automed, David Edwards, has always seen the U.S. market as a key part of the global strategy. However, the timeline was escalated after an enthusiastic response at the World Pork Expo in June. The expo opened the door to many exciting opportunities. We felt that the demand was such that we needed to act.
With the help of Tom Barragy and the Brookstone Group, we have been able to move forward with the creation of automed USA. The speed at which we have achieved this would not have been possible without their development support.
We have also added Todd Sturdy, a natural leader if there ever was one, to head up Sales for the U.S. division. He is focused on understanding the specific needs of the U.S. market and ensuring that they are met. With additions like Todd, the U.S. team will continue to grow as we seek passionate individuals that want to find solutions for the U.S. livestock industry.
The future of automed in the U.S.
From its conception, automed was always viewed as a livestock medication system with the potential to provide benefits on a global scale. The launch of automed USA is proof positive of that ambition. We couldn’t be more excited about the developments of the past month and the future of automed in the U.S. market.